affymax.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /cache/ Disallow: /_backup/ Disallow: /_mygallery/ Disallow: /_temp/ Disallow: /_tempalbums/ Disallow: /_tmpfileop/ Disallow: /dbboon/ Disallow: /Flash/ Disallow: /images/ Disallow: /mobile/ Disallow: /plugins/ Disallow: /scripts/ Disallow: /stats/ Disallow: /statshistory/ Disallow: | ||
Meta Tags
| Title | Home |
| Description | Welcome Home Home Documents Financial Reports Contact Welcome Affymax, Inc. is a biopharmaceutical company previously committed to developing novel drugs to impro |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 72.167.191.69 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
affymax.com Valuation
|
US$2,226,055
Last updated: 2023-05-11 10:09:49
affymax.com has Semrush global rank of 4,754,736. affymax.com has an estimated worth of US$ 2,226,055, based on its estimated Ads revenue. affymax.com receives approximately 256,853 unique visitors each day. Its web server is located in United States, with IP address 72.167.191.69. According to SiteAdvisor, affymax.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,226,055 |
| Daily Ads Revenue | US$2,055 |
| Monthly Ads Revenue | US$61,645 |
| Yearly Ads Revenue | US$739,736 |
| Daily Unique Visitors | 17,124 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| affymax.com. | A | 599 | IP: 72.167.191.69 |
| affymax.com. | NS | 3600 | NS Record: ns62.domaincontrol.com. |
| affymax.com. | NS | 3600 | NS Record: ns61.domaincontrol.com. |
| affymax.com. | MX | 3600 | MX Record: 0 affymax-com.mail.protection.outlook.com. |
| affymax.com. | TXT | 3600 | TXT Record: MS=ms15441279 |
| affymax.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-11 10:09:49
| Home Home Documents Financial Reports Contact Welcome Affymax, Inc. is a biopharmaceutical company previously committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. Our vision was to become a leader in the nephrology and specialty care space by delivering innovative therapeutic offerings to patients and healthcare providers before a nationwide voluntary recall of OMONTYS® (peginesatide) Injection in February 2013. In March 2013 Affymax commenced a review of strategic alternatives. Copyright © Affymax, Inc.. All rights reserved. View Desktop |
HTTP Headers
HTTP/1.1 301 Moved Permanently location: http://www.affymax.com/ Vary: Accept-Encoding Server: DPS/1.12.0 X-SiteId: 1000 Set-Cookie: dps_site_id=1000; path=/ Date: Thu, 04 Nov 2021 13:22:14 GMT Connection: keep-alive Keep-Alive: timeout=5 HTTP/1.1 404 Not Found Content-Type: text/html;charset=utf-8 Content-Length: 964 Vary: Accept-Encoding Server: DPS/1.12.0 X-SiteId: 1000 Set-Cookie: dps_site_id=1000; path=/ Date: Thu, 04 Nov 2021 13:22:14 GMT Connection: keep-alive Keep-Alive: timeout=5 |
affymax.com Whois Information
Domain Name: AFFYMAX.COM Registry Domain ID: 2823952_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-02-10T15:09:22Z Creation Date: 1993-02-08T05:00:00Z Registry Expiry Date: 2022-02-09T05:00:00Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS61.DOMAINCONTROL.COM Name Server: NS62.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-10-26T06:57:49Z <<< |